Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe

Glenmark Specialty, a Switzerland-based unit of the company, has entered into an exclusive licensing agreement with the Menarini Group for Ryaltris, the Mumbai-based drug firm said in a statement.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news